IL6 and chronic obstructive pulmonary disease: Genome-wide association studies (GWASs) have identified numerous genetic variants associated with COPD risk, encompassing genes involved in inflammatory pathways (e.g., IL-6, TNF), antioxidant defense mechanisms (e.g., glutathione S-transferase), and lung development (e.g., surfactant proteins) [23].